217 related articles for article (PubMed ID: 11485173)
1. Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and beta-cyclodextrin: FT-IR and 1H-NMR studies.
Ghorab MK; Adeyeye MC
Pharm Dev Technol; 2001 Aug; 6(3):315-24. PubMed ID: 11485173
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin.
Ghorab MK; Adeyeye MC
Pharm Dev Technol; 2001 Aug; 6(3):305-14. PubMed ID: 11485172
[TBL] [Abstract][Full Text] [Related]
3. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of process-induced fast-dissolving ibuprofen cogranulated with beta-cyclodextrin.
Ghorab MK; Adeyeye MC
J Pharm Sci; 2003 Aug; 92(8):1690-7. PubMed ID: 12884255
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of various processes for simultaneous complexation and granulation to incorporate drug-cyclodextrin complexes into solid dosage forms.
Gyanani V; Siddalingappa B; Betageri GV
Drug Dev Ind Pharm; 2015; 41(11):1856-63. PubMed ID: 25754112
[TBL] [Abstract][Full Text] [Related]
6. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
8. High shear mixing granulation of ibuprofen and beta-cyclodextrin: effects of process variables on ibuprofen dissolution.
Ghorab MK; Adeyeye MC
AAPS PharmSciTech; 2007 Oct; 8(4):E84. PubMed ID: 18181545
[TBL] [Abstract][Full Text] [Related]
9. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
10. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
11. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
12. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
14. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
Chowdary KP; Nalluri BN
Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
[TBL] [Abstract][Full Text] [Related]
15. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
[TBL] [Abstract][Full Text] [Related]
16. Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies.
di Cagno M; Stein PC; Skalko-Basnet N; Brandl M; Bauer-Brandl A
J Pharm Biomed Anal; 2011 Jun; 55(3):446-51. PubMed ID: 21411261
[TBL] [Abstract][Full Text] [Related]
17. Fast Dissolving Oral Drug Delivery System Based on Electrospun Nanofibrous Webs of Cyclodextrin/Ibuprofen Inclusion Complex Nanofibers.
Celebioglu A; Uyar T
Mol Pharm; 2019 Oct; 16(10):4387-4398. PubMed ID: 31436100
[TBL] [Abstract][Full Text] [Related]
18. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.
Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P
J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385
[TBL] [Abstract][Full Text] [Related]
19. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.
Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ
Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
